Literature DB >> 26339055

Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.

Laura Pacini1, Claudia Savini1, Raffaella Ghittoni1, Djamel Saidj1, Jerome Lamartine2, Uzma A Hasan3, Rosita Accardi1, Massimo Tommasino4.   

Abstract

UNLABELLED: Innate immunity is the first line of host defense against infections. Many oncogenic viruses can deregulate several immune-related pathways to guarantee the persistence of the infection. Here, we show that the cutaneous human papillomavirus 38 (HPV38) E6 and E7 oncoproteins suppress the expression of the double-stranded DNA sensor Toll-like receptor 9 (TLR9) in human foreskin keratinocytes (HFK), a key mediator of the antiviral innate immune host response. In particular, HPV38 E7 induces TLR9 mRNA downregulation by promoting accumulation of ΔNp73α, an antagonist of p53 and p73. Inhibition of ΔNp73α expression by antisense oligonucleotide in HPV38 E6/E7 HFK strongly rescues mRNA levels of TLR9, highlighting a key role of ΔNp73α in this event. Chromatin immunoprecipitation experiments showed that ΔNp73α is part of a negative transcriptional regulatory complex with IκB kinase beta (IKKβ) that binds to a NF-κB responsive element within the TLR9 promoter. In addition, the Polycomb protein enhancer of zeste homolog 2 (EZH2), responsible for gene expression silencing, is also recruited into the complex, leading to histone 3 trimethylation at lysine 27 (H3K27me3) in the same region of the TLR9 promoter. Ectopic expression of TLR9 in HPV38 E6/E7 cells resulted in an accumulation of the cell cycle inhibitors p21(WAF1) and p27(Kip1), decreased CDK2-associated kinase activity, and inhibition of cellular proliferation. In summary, our data show that HPV38, similarly to other viruses with well-known oncogenic activity, can downregulate TLR9 expression. In addition, they highlight a new role for TLR9 in cell cycle regulation. IMPORTANCE: The mucosal high-risk HPV types have been clearly associated with human carcinogenesis. Emerging lines of evidence suggest the involvement of certain cutaneous HPV types in development of skin squamous cell carcinoma, although this association is still under debate. Oncogenic viruses have evolved different strategies to hijack the host immune system in order to guarantee the persistence of the infection. Their capability to evade the immune system is as important as their ability to promote cellular transformation. Therefore, understanding the viral mechanisms involved in viral persistence is a valid tool to evaluate their potential role in human carcinogenesis. Here, we show that E6 and E7 oncoproteins from the cutaneous HPV38 downregulate the expression of the double-stranded DNA sensor TLR9 of innate immunity. We also present evidence that the HPV38-mediated downregulation of TLR9 expression, in addition to its potential impact on the innate immune response, is linked to cell cycle deregulation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26339055      PMCID: PMC4645680          DOI: 10.1128/JVI.02151-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

Authors:  Michiel van Gent; Bryan D Griffin; Eufemia G Berkhoff; Daphne van Leeuwen; Ingrid G J Boer; Marlyse Buisson; Franca C Hartgers; Wim P Burmeister; Emmanuel J Wiertz; Maaike E Ressing
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

2.  EBV latent membrane protein 1 is a negative regulator of TLR9.

Authors:  Ikbal Fathallah; Peggy Parroche; Henri Gruffat; Claudia Zannetti; Hanna Johansson; Jiping Yue; Evelyn Manet; Massimo Tommasino; Bakary S Sylla; Uzma A Hasan
Journal:  J Immunol       Date:  2010-10-27       Impact factor: 5.422

3.  Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.

Authors:  Rosita Accardi; Wen Dong; Anouk Smet; Rutao Cui; Agnes Hautefeuille; Anne-Sophie Gabet; Bakary S Sylla; Lutz Gissmann; Pierre Hainaut; Massimo Tommasino
Journal:  EMBO Rep       Date:  2006-01-06       Impact factor: 8.807

Review 4.  Antiviral signaling through pattern recognition receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  J Biochem       Date:  2006-12-26       Impact factor: 3.387

5.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

Review 6.  Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.

Authors:  Ivan Hirsch; Christophe Caux; Uzma Hasan; Nathalie Bendriss-Vermare; Daniel Olive
Journal:  Trends Immunol       Date:  2010-09-09       Impact factor: 16.687

7.  Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.

Authors:  Heather J Martin; Jae Myun Lee; Dermot Walls; S Diane Hayward
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

8.  Transcriptional regulation of the human TLR9 gene.

Authors:  Fumihiko Takeshita; Koichi Suzuki; Shin Sasaki; Norihisa Ishii; Dennis M Klinman; Ken J Ishii
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

9.  The Toll-like receptor gene family is integrated into human DNA damage and p53 networks.

Authors:  Daniel Menendez; Maria Shatz; Kathleen Azzam; Stavros Garantziotis; Michael B Fessler; Michael A Resnick
Journal:  PLoS Genet       Date:  2011-03-31       Impact factor: 5.917

10.  The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.

Authors:  Uzma A Hasan; Claudia Zannetti; Peggy Parroche; Nadège Goutagny; Marine Malfroy; Guillaume Roblot; Christine Carreira; Ishraq Hussain; Martin Müller; Joyce Taylor-Papadimitriou; Didier Picard; Bakary S Sylla; Giorgio Trinchieri; Ruslan Medzhitov; Massimo Tommasino
Journal:  J Exp Med       Date:  2013-06-10       Impact factor: 14.307

View more
  19 in total

Review 1.  Manipulation of the innate immune response by human papillomaviruses.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

Review 2.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

3.  TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.

Authors:  Cecilia Martínez-Campos; Margarita Bahena-Román; Kirvis Torres-Poveda; Ana I Burguete-García; Vicente Madrid-Marina
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-17       Impact factor: 4.553

Review 4.  Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.

Authors:  Assunta Venuti; Stefan Lohse; Massimo Tommasino; Sigrun Smola
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

5.  Association between Tissue Expression of Toll-Like Receptor and Some Clinicopathological Indices in Oral Squamous Cell Carcinoma.

Authors:  Reza Zare; Kazem Anvari; Farnaz Mohajertehran; Alieh Farshbaf; Atessa Pakfetrat; Amir Houshang Ansari; Maryam Ghelichli; Nooshin Mohtasham
Journal:  Rep Biochem Mol Biol       Date:  2022-07

6.  UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.

Authors:  Laura Pacini; Maria Grazia Ceraolo; Assunta Venuti; Giusi Melita; Uzma A Hasan; Rosita Accardi; Massimo Tommasino
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 7.  Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

Authors:  Natalie Vandeven; Paul Nghiem
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

Review 8.  Modulation of antigen presenting cell functions during chronic HPV infection.

Authors:  Abate Assefa Bashaw; Graham R Leggatt; Janin Chandra; Zewen K Tuong; Ian H Frazer
Journal:  Papillomavirus Res       Date:  2017-08-18

9.  TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression.

Authors:  P Parroche; G Roblot; F Le Calvez-Kelm; I Tout; M Marotel; M Malfroy; G Durand; J McKay; M Ainouze; C Carreira; O Allatif; A Traverse-Glehen; M Mendiola; J J Pozo-Kreilinger; C Caux; M Tommasino; N Goutagny; U A Hasan
Journal:  Oncogenesis       Date:  2016-07-25       Impact factor: 7.485

10.  Prevalence of cutaneous beta and gamma human papillomaviruses in the anal canal of men who have sex with women.

Authors:  Vitaly Smelov; Rachel Hanisch; Sandrine McKay-Chopin; Olga Sokolova; Carina Eklund; Boris Komyakov; Tarik Gheit; Massimo Tommasino
Journal:  Papillomavirus Res       Date:  2017-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.